Novel biomarkers may provide guide to personalized hepatitis C therapy

A simple blood test can be used to predict which chronic hepatitis C patients will respond to interferon-based therapy, according to a report. Hepatitis C chronically infects about 160 million people worldwide, and is a major cause of illness and death from hepatocellular carcinoma and end-stage liver disease.

from Today's Healthcare News -- ScienceDaily http://ift.tt/1QJVwHh